Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term in-vitro. Found 62 abstracts

no pagination
Chow HY, Jubb AM, Koch JN, Jaffer ZM, Stepanova D, Campbell DA, Duron SG, O'Farrell M, Cai KQ, Klein-Szanto AJ, Gutkind JS, Hoeflich KP, Chernoff J. p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model. Cancer Research. 2012 Nov;72(22):5966-75.   PMCID: PMC3500416
del Blanco B, Garcia-Mariscal A, Wiest DL, Hernandez-Munain C. Tcra Enhancer Activation by Inducible Transcription Factors Downstream of Pre-TCR Signaling. Journal of Immunology. 2012 Apr;188(7):3278-93.   PMCID: NOT nih FUNDED
Hakanson M, Kobel S, Lutolf MP, Textor M, Cukierman E, Charnley M. Controlled Breast Cancer Microarrays for the Deconvolution of Cellular Multilayering and Density Effects upon Drug Responses. Plos One. 2012 Jun;7(6):e40141.   PMCID: PMC3387021
Leonard JP, LaCasce AS, Smith MR, Noy A, Chirieac LR, Rodig SJ, Yu JQ, Vallabhajosula S, Schoder H, English P, Neuberg DS, Martin P, Millenson MM, Ely SA, Courtney R, Shaik N, Wilner KD, Randolph S, Van den Abbeele AD, Chen-Kiang SY, Yap JT, Shapiro GI. Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. Blood. 2012 May;119(20):4597-607.   PMCID: not NIH funded
Makhov P, Golovine K, Canter D, Kutikov A, Simhan J, Corlew MM, Uzzo RG, Kolenko VM. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity. The Prostate. 2012 May;72(6):661-7.   PMCID: PMC3208085
Malofeeva EV, Domanitskaya N, Gudima M, Hopper-Borge EA. Modulation of the ATPase and Transport Activities of Broad-Acting Multidrug Resistance Factor ABCC10 (MRP7). Cancer Research. 2012 Dec;72(24):6457-67.   PMCID: PMC 3525726
Schonrath K, Klein-Szanto AJ, Braunewell KH. The putative Tumor Suppressor VILIP-1 Counteracts Epidermal Growth Factor-Induced Epidermal-Mesenchymal Transition in Squamous Carcinoma Cells. Plos One. 2012 Mar;7(3):e33116.   PMCID: PMC3316558
Vadakara J, Pro B. Targeting CD30 in Anaplastic Large Cell Lymphoma. Current Hematologic Malignancy Reports. 2012 Dec;7(4):285-91.   PMCID: Not NIH fund
Zhou Y, Goenaga AL, Harms BD, Zou H, Lou JL, Conrad F, Adams GP, Schoeberl B, Nielsen UB, Marks JD. Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies. Molecular Cancer Therapeutics. 2012 Jul;11(7):1467-76.
Katz RA, Merkel G, Andrake MD, Roder H, Skalka AM. Retroviral Integrases Promote Fraying of Viral DNA Ends. Journal of Biological Chemistry. 2011 Jul;286(29):25710-8.   PMCID: PMC3138259
Liao SR, Toczylowski T, Yan H. Mechanistic analysis of Xenopus EXO1's function in 5'-strand resection at DNA double-strand breaks. Nucleic acids research. 2011 Aug;39(14):5967-77.   PMCID: PMC3152354
Makhlin I, Zhang J, Long CJ, Devarajan K, Zhou Y, Klein-Szanto AJ, Huang M, Chernoff J, Boorjian SA. The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers. BJU international. 2011 Jul;108(2B):E84-E90.   PMCID: PMC3116980
Plotnikova OV, Golemis EA. Aurora A kinase activity influences calcium signaling in kidney cells. Journal of Cell Biology. 2011 Jun;193(6):1021-32.   PMCID: PMC3115793
Golovine K, Makhov P, Uzzo RG, Kutikov A, Kaplan DJ, Fox E, Kolenko VM. Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappa B-independent, proteasome-mediated mechanism - art. no. 183. Molecular Cancer. 2010 Jul;9:183.   PMCID: PMC3044330
Mabuchi S, Kawase C, Altomare DA, Morishige K, Hayashi M, Sawada K, Ito K, Terai Y, Nishio Y, Klein-Szanto AJ, Burger RA, Ohmichi M, Testa JR, Kimura T. Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary. Molecular Cancer Therapeutics. 2010 Aug;9(8):2411-22.   PMCID: PMC2941981 [Available on 2011/8/1]
Ohashi S, Natsuizaka M, Wong GS, Michaylira CZ, Grugan KD, Stairs DB, Kalabis J, Vega ME, Kalman RA, Nakagawa M, Klein-Szanto AJ, Herlyn M, Diehl JA, Rustgi AK, Nakagawa H. Epidermal Growth Factor Receptor and Mutant p53 Expand an Esophageal Cellular Subpopulation Capable of Epithelial-to-Mesenchymal Transition through ZEB Transcription Factors. Cancer Research. 2010 May;70(10):4174-84.   PMCID: PMC3007622
Robertson FM, Ogasawara MA, Ye ZM, Chu K, Pickei R, Debeb BG, Woodward WA, Hittelman WN, Cristofanilli M, Barsky SH. Imaging and Analysis of 3D Tumor Spheroids Enriched for a Cancer Stem Cell Phenotype. Journal of Biomolecular Screening. 2010 Aug;15(7):820-9.   PMCID: not NIH funded
Singh MK, Izumchenko E, Klein-Szanto AJ, Egleston BL, Wolfson M, Golemis EA. Enhanced Genetic Instability and Dasatinib Sensitivity in Mammary Tumor Cells Lacking NEDD9. Cancer Research. 2010 Nov;70(21):8907-16.   PMCID: PMC2970659
Younes A, Vose JM, Zelenetz AD, Smith MR, Burris HA, Ansell SM, Klein J, Halpern W, Miceli R, Kumm E, Fox NL, Czuczman MS. A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma. British Journal of Cancer. 2010 Dec;103(12):1783-7.   PMCID: PMCID: PMC3008610 [Available on 2011/12/7]
Aquino JB, Lallemend F, Marmigere F, Adameyko, Golemis EA, Ernfors P. The retinoic acid inducible Cas-Family signaling protein Nedd9 regulates neural crest cell migration by modulating adhesion and actin dynamics. Neuroscience. 2009 Sep;162(4):1106-19.   PMCID: PMC2653735
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term in-vitro

in-vitro cancer expression monoclonal-antibody inhibition phase-ii breast-cancer identification tumor-necrosis-factor activation migration antitumor-activity hepatocellular-carcinoma differentiation cancer-cells epithelial-cells overexpression tumor spheroids protein hef1 concerted tissue architecture protein-kinase metastatic colorectal-cancer apoptosis-protein non-hodgkins-lymphoma keratinocyte cyclosporine-a modeling analysis cells botulinum neurotoxin pd 0332991 substrate egg extracts recognition yeast mek inhibitor pd0325901 therapeutic strategy thermo-reversible cell mutations enhancement senescence polycystin-2 CD30 Anaplastic large cell lymphoma-SGN-35-Brentuximab-Vedotin-MMAE-T-cell lymphoma ribosome-inactivating proteins aurora-a beta(1) integrin inflammatory breast-carcinoma piperine nucleotide-binding growth channel activity mutation avoidance squamous-cell carcinomas repressors zeb1 akt visinin-like protein-1 molecular-mechanisms transcription factors drug-interactions transforming growth-factor-beta-1 homologous recombination kinase cycloaddition radical cystectomy motility strand transfer nude-mice pathogenesis lung-cancer brentuximab vedotin sgn-35 apoptosis-inducing ligand metabolism docking protein emt free click chemistry human angiogenin integrin antisense oligonucleotides repair nervous-system end resection rapamycin mitotic spindle anticancer dependent kinase inhibitor site barrier deficient mice cyclin d1 glycoprotein thymocyte tgf-beta n-cadherin protein-7 abcc10 lines 1993 chasseval r-european journal of immunology-v23-p1294 centrosome amplification e-cadherin expression drug-resistance pak protein-kinases imaging extracellular-matrix anti-cd30 sarcoma virus integrase mammalian target 2011 lblanco b-genetics res int inflammatory breast cancer bladder cancer hydrolysis mouse model human exonuclease 1 targets agonistic monoclonal-antibody EdU confocal microscopy Cas-L HEF1-cytoskeleton-focal adhesion-multipotency-RA chemotherapy resistance kinase inhibitor p27(kip1) lymphovascular angiogenesis t-cell development conditional expression receptor-alpha-gene peptides mir-200 family t-lymphocytes kidney cells iap growth-factor receptor factor-related cell-death mountant CyGEL (TM) factor-binding sites embolus scid mice 1995 boer cj-oncogene-v10-p1833 integration dna-binding centrocytic lymphoma receptors trail-r1 distinct ca dinucleotide click chemistry apoptosis TRAIL-Apo2L bevacizumab gynecologic-oncology-group p-glycoprotein atpase hiv-1 integrase werner-syndrome protein tumor progression
Last updated on Tuesday, July 03, 2018